Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...

Johnson & Johnson’s latest results show resilient pharmaceutical growth but softer medical-device sales, raising a key question for dividend investors: can its competitive moat justify a premium ...

Soon if you visit a medical specialist, you may notice a fact sheet plastered on the wall. It will encourage you to ask questions, and outline five simple things to consider when speaking to your ...

OpenAI is giving $5 million to help mathematicians make sense of AI-generated research. “Staggering.” “Overwhelming.” “Unprecedented.” “Surreal.” “Pure insanity.” Those were among the descriptions ...

On the eve of New Scientist’s 70th anniversary, newsroom legend Andy Coghlan reveals four of the most dramatic and surprising ...

Washington State University researchers have engineered a targeted nanotherapy that could yield a medical breakthrough to ...

Becton, Dickinson and Company (NYSE:BDX) has steady demand for its medical devices, together with a long history of paying ...

Companies are required to warn that experimental peptides, which haven’t been approved by the FDA, are for research use only.

Anmol Saini’s medical research is helping to give hope to South Australian women who are struggling to become pregnant.

(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...

From cutting heart valves without open-heart surgery to confronting Israel’s growing medical brain drain, Sheba cardiologist ...

NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.